C

hris brings to Capstone over 30 years of experience developing and commercializing of a diverse array of drug substance platforms and drug product dosage forms. Most recently, Chris was the SVP, Technical Operations and Chief Manufacturing Officer at Halozyme Therapeutics, where he was responsible for leading all manufacturing, development and supply chain activities growing Halozymes rHUPH20 ENHANZE and Antares Autoinjector platform technologies. Chris has held multiple product development and operational roles across the pharmaceutical and biotechnology industry, including his role as Chief Scientific Officer at Fresenius Kabi-North America, Vice President of Technical Operations for Levo Therapeutics and Kastle Therapeutics. He holds a Ph.D. in Organic Chemistry from the University of California, San Diego.